1. Home
  2. QUBT vs ANIP Comparison

QUBT vs ANIP Comparison

Compare QUBT & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Computing Inc.

QUBT

Quantum Computing Inc.

HOLD

Current Price

$11.29

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$82.47

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUBT
ANIP
Founded
2001
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
2019
1999

Fundamental Metrics

Financial Performance
Metric
QUBT
ANIP
Price
$11.29
$82.47
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$17.50
$110.00
AVG Volume (30 Days)
18.6M
296.7K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
84.93
419.23
EPS
N/A
1.28
Revenue
$682,000.00
$206,547,000.00
Revenue This Year
$3,210.56
$21.01
Revenue Next Year
$51.26
$17.59
P/E Ratio
N/A
$63.96
Revenue Growth
82.84
2.47
52 Week Low
$6.18
$56.71
52 Week High
$25.84
$99.50

Technical Indicators

Market Signals
Indicator
QUBT
ANIP
Relative Strength Index (RSI) 59.49 57.17
Support Level $10.12 $77.32
Resistance Level $13.14 $83.58
Average True Range (ATR) 1.04 3.19
MACD -0.05 -0.06
Stochastic Oscillator 40.40 54.55

Price Performance

Historical Comparison
QUBT
ANIP

About QUBT Quantum Computing Inc.

Quantum Computing Inc is an integrated photonics and non-linear quantum optics company to develop and deliver machines for quantum computing, reservoir computing, and remote sensing, imaging, and cybersecurity applications based on patented and proprietary photonics technology. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offers capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: